ConductScience.org, home

Paper42005455

Significance of SLC1A5 expression in head and neck squamous cell carcinoma: A bioinformatics and in-vitro analysis.

Kaarunya S and 3 others. J Oral Biol Craniofac Res, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Significance of SLC1A5 expression in head and neck squamous cell carcinoma: A bioinformatics and in-vitro analysis. Papers, record 42005455. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42005455

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Significance of SLC1A5 expression in head and neck squamous cell carcinoma: A bioinformatics and in-vitro analysis.
PubMed
Journal
J Oral Biol Craniofac Res
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kaarunya SS
2Sinduja PPalati
3Yuwanati MMonal
4Mullainathan SSenthilmurugan

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129326164The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5).J Biol Chem2018https://conductscience.org/library/papers/29326164PubMed
233953707Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment.Front Immunol2021https://conductscience.org/library/papers/33953707PubMed
339223142The disruption of NEAT1-miR-125b-5p-SLC1A5 cascade defines the oncogenicity and differential immune profile in head and neck squamous cell carcinoma.Cell Death Discov2024https://conductscience.org/library/papers/39223142PubMed
431866442A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells.Cell Metab2020https://conductscience.org/library/papers/31866442PubMed
540362545The Possibility of Plasma Membrane Transporters as Drug Targets in Oral Cancers.Int J Mol Sci2025https://conductscience.org/library/papers/40362545PubMed
638844930Elevated SLC1A5 associated with poor prognosis and therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma.J Transl Med2024https://conductscience.org/library/papers/38844930PubMed
736950604SLC1A5, unrelated to prognosis, was associated with CD8+ T-cell exclusion in the tumor microenvironment of squamous cell carcinoma.Heliyon2023https://conductscience.org/library/papers/36950604PubMed
841184297Targeting cancer glutamine dependency with a first-in-class inhibitor of the mitochondrial glutamine transporter SLC1A5_var.Nat Commun2025https://conductscience.org/library/papers/41184297PubMed
934171602Comprehensive molecular and clinical characterization of SLC1A5 in human cancers.Pathol Res Pract2021https://conductscience.org/library/papers/34171602PubMed
1014557543Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution.Proc Natl Acad Sci U S A2003https://conductscience.org/library/papers/14557543PubMed
1139335197The Solute Carrier (SLC) Transporter Superfamily as Therapeutic Targets for the Treatment of Head and Neck Squamous Cell Carcinoma.Cancers (Basel)2024https://conductscience.org/library/papers/39335197PubMed
1237752146Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic interventions.Signal Transduct Target Ther2023https://conductscience.org/library/papers/37752146PubMed
1338000245Prediction and related genes of cancer distant metastasis based on deep learning.Comput Biol Med2024https://conductscience.org/library/papers/38000245PubMed
1425821004Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancer.Int J Cancer2015https://conductscience.org/library/papers/25821004PubMed
1535487063Targeting of the glutamine transporter SLC1A5 induces cellular senescence in clear cell renal cell carcinoma.Biochem Biophys Res Commun2022https://conductscience.org/library/papers/35487063PubMed
1635794606Bladder cancer-derived exosomal KRT6B promotes invasion and metastasis by inducing EMT and regulating the immune microenvironment.J Transl Med2022https://conductscience.org/library/papers/35794606PubMed
1739660050Crosstalk between metabolic and epigenetic modifications during cell carcinogenesis.iScience2024https://conductscience.org/library/papers/39660050PubMed
1840312304Integrating transcriptomic and metabolomic analyses to characterize the potential function of SLC1A5 in thyroid cancer.BMC Cancer2025https://conductscience.org/library/papers/40312304PubMed
1941264384Prognostic Factors in Patients With Locally Advanced Hypopharyngeal Squamous Cell Carcinoma After Radical Radiotherapy/Chemoradiotherapy.Cancer Med2025https://conductscience.org/library/papers/41264384PubMed
2038534987Targeting Solute Carrier Transporters (SLCs) as a Therapeutic Target in Different Cancers.Diseases2024https://conductscience.org/library/papers/38534987PubMed

See all 34 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42005455

GET https://conductscience.org/api/papers/v1/42005455/references?page=2